| 1 |
Guideline [Treatment and follow up protocol in differentiated thyroid carcinomas of follicular origin] free! 2005
Rodrigues F, Limbert E, Marques AP, Santos AP, Lopes C, Rodrigues E, Borges F, Carrilho F, Castro JJ, Neto J, Salgado L, Oliveira MJ, Anonymous00295. · No affiliation provided · Acta Med Port. · Pubmed #16202330 links to free full text
Abstract: Differentiated thyroid carcinoma of follicular origin (DTCFO), although not very frequent, has registered a raising incidence in the last decades. In the majority of the cases, DTCFO is a curable disease when treated and monitored by experienced, multidisciplinary teams. These factors contribute to an increasing number of DTCFO survivors requiring life-long monitoring, due to the possibility of occurrence of recurrences many years after the initial treatment. Several aspects of the treatment and management of these patients are still controversial. The present protocol represents the consensus of the members of the Grupo de Estudo da Tiróide of the Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. It aims to define guidelines, in agreement with the current state of the art and contemplating the necessary adaptations to local constrains, that ensure decreased mortality and protection of patients' quality of life, avoiding unnecessarily aggressive or ineffective treatments, optimizing the use of the available resources.
|
| 2 |
Article [Hypothyroidism and pregnancy] 2003
Marques AP, Santos AP, Oliveira MJ. · Serviço de Endocrinologia, Diabetes e Metabolismo, Instituto Português de Oncologia, Porto. · Acta Med Port. · Pubmed #14750276 No free full text.
Abstract: The authors refer hypothyroidism epidemiology and physiology, enhancing the need to raise thyroid hormones and also to adjust the doses of levothyrosine, normally used in the treatment. They describe the obstetric complications that can occur in non medicated hypothyroidism pregnancies, as well to the new-born baby.
|